Pacira Pharmaceuticals, Inc. v. Research Development Foundation

District Court, D. Nevada·Decided May 30, 2023·No. 2:21-cv-02241·Unknown

Opinion

2 UNITED STATES DISTRICT COURT 3 DISTRICT OF NEVADA 4 * * * 5 Pacira Pharmaceuticals, Inc., Case No. 2:21-cv-02241-CDS-DJA 6 Plaintiff, 7 Order v. 8 Research Development Foundation, 9 Defendant. 10 11 12 This is a contract dispute arising out of a royalty agreement between Pacira 13 Pharmaceuticals, Inc. and Research Development Foundation (“RDF”). Pacira sues RDF and 14 RDF counterclaims for declaratory relief regarding whether Pacira owes royalty payments to 15 RDF for certain of Pacira’s products under the agreement. Pacira moves to reopen discovery, 16 arguing that after the close of discovery, RDF: (1) submitted errata sheets to its 30(b)(6) witness’s 17 deposition that materially changed the deposition; and (2) supplemented an interrogatory response 18 with a new theory that it is entitled to royalty payments for products that use a particular 19 manufacturing process, rather than products that fall under certain patents. (ECF No. 91). Pacira 20 also filed a version of this motion under seal. (ECF No. 93). 21 After the parties fully briefed the motion to reopen discovery, the parties filed a joint 22 notice regarding the motion, explaining that the 30(b)(6) witness—Mr. Thomas Brorby—whom 23 Pacira sought to re-depose in its motion to reopen discovery, had passed away. (ECF No. 134). 24 As a result, Pacira changed its requested relief to asking the Court to strike the errata sheets, 25 which relief RDF opposes. Because the Court finds that Pacira has demonstrated good cause and 26 excusable neglect, it grants Pacira’s motion to reopen discovery (ECF No. 91) and the sealed 27 version of that motion (ECF No. 93). The Court also grants Pacira’s updated request to strike Mr. 1 I. Background. 2 Pacira moves to reopen discovery for two reasons. (ECF No. 91). First, because after the 3 close of discovery, RDF served two deposition errata sheets for Mr. Brorby—RDF’s principal 4 Rule 30(b)(6) witness and a negotiator of the agreement at issue—substantively changing Mr. 5 Brorby’s testimony. Mr. Brorby had previously testified that he had no notes to memorialize a 6 meeting regarding the agreement between Pacira and RDF. The errata sheets changed that 7 testimony to add that Mr. Brorby had a single page of handwritten notes from that meeting. 8 Second, also after the close of discovery, RDF served a supplemental response to Pacira’s 9 Interrogatory No. 4 which disclosed a new theory why RDF believes it is entitled to ongoing 10 royalty payments from Pacira. Pacira asserts that previously, RDF had asserted that it was 11 entitled to royalty payments based on certain patents. But in its supplement, RDF asserts that it is 12 entitled to royalty payments based on certain trade secrets, including a manufacturing process 13 Pacira employs. Pacira asks the Court to reopen discovery so that it can: (1) re-depose Mr. 14 Brorby regarding his errata changes; and (2) serve a single interrogatory on RDF regarding the 15 new theory and conduct a 3.5-hour Rule 30(b)(6) deposition on that theory. 16 Since Pacira filed its motion, however, Mr. Brorby has passed away. (ECF No. 134). The 17 parties thus filed a joint notice of this fact and, instead of reopening Mr. Brorby’s deposition, 18 Pacira seeks to strike the errata sheets instead. Pacira explains that, because it is now unable to 19 depose Mr. Brorby about his changes, the appropriate remedy is striking the errata sheets. 20 RDF responds that reopening discovery is unnecessary because Pacira was already aware 21 of Mr. Brorby’s handwritten notes from the meeting and because the discovery Pacira seeks to 22 remedy the issue is overbroad. (ECF No. 108). Regarding Pacira’s assertion that RDF has raised 23 a new theory, RDF asserts that its theory is not new, but that it has put its theory forth in motions 24 before. RDF also argues that the issue is ripe for summary judgment adjudication and there is no 25 reason to reopen discovery at this stage because that discovery will not change the fact that the 26 issue is ready to be decided. 27 Regarding striking Mr. Brorby’s errata sheets, RDF asserts that it will not rely on the 1 wishes to keep them so that Pacira cannot attack Mr. Brorby’s testimony as being incomplete or 2 untruthful. (ECF No. 134). RDF adds that Pacira could have sought to strike the errata in its 3 original motion to reopen, but did not. RDF asserts that, the reason Pacira would have sought 4 additional testimony in the first place was to mitigate the risk that Mr. Brorby would present new 5 facts at trial not provided in his deposition. But now that Mr. Brorby has passed away, this 6 danger is mitigated and Pacira’s request to strike the errata is moot. 7 Pacira replies that it was not aware of the notes prior to the close of discovery because Mr. 8 Brorby testified that he had no notes from the meeting. (ECF No. 112). Regarding RDF’s 9 assertion that its theory is not new, Pacira again points out that RDF previously asserted that its 10 royalty payments were tied to patents, not to a specific manufacturing process as they now assert. 11 II. Discussion. 12 A request to reopen discovery must be supported by a showing of good cause and 13 excusable neglect. Local Rule 26-3; Fed. R. Civ. P. 6(b)(1)(B). The good cause analysis turns on 14 whether the subject deadlines cannot reasonably be met despite the exercise of diligence. 15 Johnson v. Mammoth Recreations, Inc., 975 F.2d 604, 609 (9th Cir. 1992). The showing of 16 diligence is measured by the movant’s conduct throughout the entire period of time already 17 allowed. CC.Mexicano.US, LLC v. Aero II Aviation, Inc., 2015 U.S. Dist. LEXIS 169110, at *11- 18 12, 2015 WL 10059063 (D. Nev. Dec. 15, 2015). The excusable neglect “determination is at 19 bottom an equitable one, taking account of all relevant circumstances surrounding the party’s 20 omission.” Pioneer Inv. Servs. Co. v. Brunswick Assocs. Ltd. P’ship, 507 U.S. 380, 395 (1993). 21 Factors courts may consider when evaluating excusable neglect include (1) the danger of 22 prejudice to the non-moving party, (2) the length of the delay and its potential impact on judicial 23 proceedings, (3) the reason for the delay and, (4) whether the movant acted in good faith. Id. 24 Further, when determining whether to reopen discovery, courts should, 25 consider the following factors: 1) whether trial is imminent, 2) whether the request is opposed, 3) whether the non-moving party 26 would be prejudiced, 4) whether the moving party was diligent in 27 obtaining discovery within the guidelines established by the court, 5) the foreseeability of the need for additional discovery in light of the time allowed for discovery by the district court, and 6) the 1 likelihood that the discovery will lead to relevant evidence. 2 3 City of Pomona v. SQM N. Am. Corp., 866 F.3d 1060, 1066 (9th Cir. 2017) (internal 4 citation omitted). 5 Federal Rule of Civil Procedure 30 provides that, “[o]n request by the deponent or a party 6 before the deposition is completed, the deponent must be allowed 30 days after being notified by 7 the officer that the transcript or recording is available in which: (A) to review the transcript of 8 recording; and (B) if there are changes in form or substance, to sign a statement listing the 9 changes and the reasons for making them.” Fed. R. Civ. P. 30(e)(1).

Free access — add to your briefcase to read the full text and ask questions with AI

Pacira Pharmaceuticals, Inc. v. Research Development Foundation, (D. Nev. 2023).

Pacira Pharmaceuticals, Inc. v. Research Development Foundation (Pacira Pharmaceuticals, Inc. v. Research Development Foundation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related